CA Stock MarketDetailed Quotes

Restart Life Sciences Corp (HEAL.X)

Watchlist
  • 0.025
  • 0.0000.00%
15min DelayMarket Closed Dec 17 13:21 ET
900.60KMarket Cap-0.25P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Restart Life Sciences Corp (HEAL.X) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
28.35K
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--28.35K
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
0
Operating expense
-43.63%123.46K
-70.03%90.75K
-72.43%145.56K
-51.82%219.04K
-24.12%302.79K
-20.25%528.01K
-33.97%1.94M
-8.22%421.54K
-68.26%454.58K
-6.10%399.04K
Selling and administrative expenses
-59.76%63.84K
-86.16%28.06K
-80.61%84.49K
-53.03%158.64K
-33.11%202.65K
-24.18%435.71K
-12.46%1.56M
-29.90%344.39K
-58.20%337.75K
43.75%302.97K
-General and administrative expense
-59.76%63.84K
-86.16%28.06K
-80.61%84.49K
-53.03%158.64K
-33.11%202.65K
-24.18%435.71K
-12.46%1.56M
-29.90%344.39K
-58.20%337.75K
43.75%302.97K
Research and development costs
--0
--0
-98.45%500
-99.58%181
-19.01%38.26K
48.50%32.19K
-86.61%115.16K
103.55%3.42K
-92.35%42.83K
-66.62%47.24K
Depreciation amortization depletion
-21.47%578
-21.50%577
-21.36%578
-22.36%736
-22.47%735
-22.47%735
-24.13%3.79K
-24.16%948
-24.10%948
-53.60%948
-Depreciation and amortization
-21.47%578
-21.50%577
-21.36%578
-22.36%736
-22.47%735
-22.47%735
-24.13%3.79K
-24.16%948
-24.10%948
-53.60%948
Other operating expenses
-0.73%59.05K
1.59%62.12K
1.06%60K
-18.58%59.49K
27.72%61.15K
-8.40%59.37K
-9.97%258.53K
15.65%72.79K
14.77%73.06K
-32.24%47.88K
Operating profit
35.26%-123.46K
70.03%-90.75K
72.43%-145.56K
58.05%-190.69K
24.12%-302.79K
20.25%-528.01K
33.97%-1.94M
8.22%-421.54K
68.26%-454.58K
6.10%-399.04K
Net non-operating interest income (expenses)
0
0
-50.00%1
-87.55%6.63K
0
-99.99%2
135.70%230.08K
11.92%104.15K
53.25K
835.06%37.5K
Non-operating interest income
--0
--0
-50.00%1
-87.55%6.63K
--0
-99.99%2
135.70%230.08K
11.92%104.15K
--53.25K
835.06%37.5K
Other net income (expenses)
583.03K
174
1.18K
-599.65%-758.69K
-713.20%-751.84K
-105.50%-1.61K
-5.25K
Gain on sale of security
---1.76K
----
----
----
----
----
----
----
----
----
Special income (charges)
--584.79K
----
----
--0
----
----
-13,993.12%-766.38K
-13,867.01%-759.53K
---1.61K
---5.25K
-Less:Write off
----
----
----
----
----
----
13,993.12%766.38K
13,867.01%759.53K
--1.61K
--5.25K
-Gain on sale of property,plant,equipment
--584.79K
----
----
--0
----
----
----
----
----
----
Other non-operating income (expenses)
----
--174
--1.18K
----
----
----
-94.21%7.69K
----
----
----
Income before tax
349.68%459.57K
70.09%-90.58K
72.66%-144.38K
54.32%-184.06K
17.45%-302.79K
15.78%-528.01K
8.15%-2.47M
-338.91%-1.07M
71.28%-402.94K
12.87%-366.79K
Income tax
Earnings from equity interest net of tax
Net income
349.68%459.57K
70.09%-90.58K
72.66%-144.38K
54.32%-184.06K
17.45%-302.79K
15.78%-528.01K
8.15%-2.47M
-338.91%-1.07M
71.28%-402.94K
12.87%-366.79K
Net income continuous operations
349.68%459.57K
70.09%-90.58K
72.66%-144.38K
54.32%-184.06K
17.45%-302.79K
15.78%-528.01K
8.15%-2.47M
-338.91%-1.07M
71.28%-402.94K
12.87%-366.79K
Noncontrolling interests
Net income attributable to the company
349.68%459.57K
70.09%-90.58K
72.66%-144.38K
54.32%-184.06K
17.45%-302.79K
15.78%-528.01K
8.15%-2.47M
-338.91%-1.07M
71.28%-402.94K
12.87%-366.79K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
349.68%459.57K
70.09%-90.58K
72.66%-144.38K
54.32%-184.06K
17.45%-302.79K
15.78%-528.01K
8.15%-2.47M
-338.91%-1.07M
71.28%-402.94K
12.87%-366.79K
Diluted earnings per share
300.00%0.02
70.28%-0.0031
73.11%-0.0049
29.35%-0.01
20.12%-0.0103
63.74%-0.0181
0.00%-0.1
-0.05
71.69%-0.0142
31.97%-0.0129
Basic earnings per share
300.00%0.02
70.28%-0.0031
73.11%-0.0049
29.35%-0.01
20.12%-0.0103
63.74%-0.0181
0.00%-0.1
-0.05
71.69%-0.0142
31.97%-0.0129
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 00028.35K000000
Operating revenue --0--0--0--28.35K--0--0--0--0--0--0
Cost of revenue
Gross profit 0
Operating expense -43.63%123.46K-70.03%90.75K-72.43%145.56K-51.82%219.04K-24.12%302.79K-20.25%528.01K-33.97%1.94M-8.22%421.54K-68.26%454.58K-6.10%399.04K
Selling and administrative expenses -59.76%63.84K-86.16%28.06K-80.61%84.49K-53.03%158.64K-33.11%202.65K-24.18%435.71K-12.46%1.56M-29.90%344.39K-58.20%337.75K43.75%302.97K
-General and administrative expense -59.76%63.84K-86.16%28.06K-80.61%84.49K-53.03%158.64K-33.11%202.65K-24.18%435.71K-12.46%1.56M-29.90%344.39K-58.20%337.75K43.75%302.97K
Research and development costs --0--0-98.45%500-99.58%181-19.01%38.26K48.50%32.19K-86.61%115.16K103.55%3.42K-92.35%42.83K-66.62%47.24K
Depreciation amortization depletion -21.47%578-21.50%577-21.36%578-22.36%736-22.47%735-22.47%735-24.13%3.79K-24.16%948-24.10%948-53.60%948
-Depreciation and amortization -21.47%578-21.50%577-21.36%578-22.36%736-22.47%735-22.47%735-24.13%3.79K-24.16%948-24.10%948-53.60%948
Other operating expenses -0.73%59.05K1.59%62.12K1.06%60K-18.58%59.49K27.72%61.15K-8.40%59.37K-9.97%258.53K15.65%72.79K14.77%73.06K-32.24%47.88K
Operating profit 35.26%-123.46K70.03%-90.75K72.43%-145.56K58.05%-190.69K24.12%-302.79K20.25%-528.01K33.97%-1.94M8.22%-421.54K68.26%-454.58K6.10%-399.04K
Net non-operating interest income (expenses) 00-50.00%1-87.55%6.63K0-99.99%2135.70%230.08K11.92%104.15K53.25K835.06%37.5K
Non-operating interest income --0--0-50.00%1-87.55%6.63K--0-99.99%2135.70%230.08K11.92%104.15K--53.25K835.06%37.5K
Other net income (expenses) 583.03K1741.18K-599.65%-758.69K-713.20%-751.84K-105.50%-1.61K-5.25K
Gain on sale of security ---1.76K------------------------------------
Special income (charges) --584.79K----------0---------13,993.12%-766.38K-13,867.01%-759.53K---1.61K---5.25K
-Less:Write off ------------------------13,993.12%766.38K13,867.01%759.53K--1.61K--5.25K
-Gain on sale of property,plant,equipment --584.79K----------0------------------------
Other non-operating income (expenses) ------174--1.18K-------------94.21%7.69K------------
Income before tax 349.68%459.57K70.09%-90.58K72.66%-144.38K54.32%-184.06K17.45%-302.79K15.78%-528.01K8.15%-2.47M-338.91%-1.07M71.28%-402.94K12.87%-366.79K
Income tax
Earnings from equity interest net of tax
Net income 349.68%459.57K70.09%-90.58K72.66%-144.38K54.32%-184.06K17.45%-302.79K15.78%-528.01K8.15%-2.47M-338.91%-1.07M71.28%-402.94K12.87%-366.79K
Net income continuous operations 349.68%459.57K70.09%-90.58K72.66%-144.38K54.32%-184.06K17.45%-302.79K15.78%-528.01K8.15%-2.47M-338.91%-1.07M71.28%-402.94K12.87%-366.79K
Noncontrolling interests
Net income attributable to the company 349.68%459.57K70.09%-90.58K72.66%-144.38K54.32%-184.06K17.45%-302.79K15.78%-528.01K8.15%-2.47M-338.91%-1.07M71.28%-402.94K12.87%-366.79K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 349.68%459.57K70.09%-90.58K72.66%-144.38K54.32%-184.06K17.45%-302.79K15.78%-528.01K8.15%-2.47M-338.91%-1.07M71.28%-402.94K12.87%-366.79K
Diluted earnings per share 300.00%0.0270.28%-0.003173.11%-0.004929.35%-0.0120.12%-0.010363.74%-0.01810.00%-0.1-0.0571.69%-0.014231.97%-0.0129
Basic earnings per share 300.00%0.0270.28%-0.003173.11%-0.004929.35%-0.0120.12%-0.010363.74%-0.01810.00%-0.1-0.0571.69%-0.014231.97%-0.0129
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------------Unqualified Opinion with Explanatory Notes------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +4.00%
Sample Name
Sample Code
 +2.86%
4
SINOPEC CORP
00386
+2.22%
5
CNOOC
00883
+1.66%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +46.25%
Sample Name
Sample Code
 +33.47%
Sample Name
Sample Code
 +26.48%
4
Loongson Technology Corporation
688047
+24.63%
5
Rockchip Electronics
603893
+19.54%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -